MDMarc Danguy Des Déserts

Marc Danguy Des Déserts

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc Danguy Des Déserts has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Diane Commandeur

    9 shared publications
  • Christophe Giacardi

    Military Teaching Hospital Clermont Tonnerre, Boulevard Colonel Fonferrier, 29200 Brest, France

    7 shared publications
  • Ba Vinh Nguyen

    Clermont-Tonnerre Military Teaching Hospital, Brest 29200, France; French Military Health Service Academy, École du Val-de-Grâce, Paris 75000, France; Bégin Military Teaching Hospital, Saint Mandé 94160, France

    6 shared publications
  • Johan Schmitt

    Intensive Care Unit, Military Teaching Hospital Sainte Anne , Toulon, 83000

    6 shared publications
  • D. Commandeur

    5 shared publications
  • Isabelle Drouillard

    Pôle médico-technique (pharmacie-fédération des laboratoires-imagerie médicale), Hôpital d'instruction des armées Clermont Tonnerre, BCRM de Brest, France

    5 shared publications

Latest Publications

  • Impact de l'inflammation, de la dysfonction endothéliale et de la fibrinolyse sur le risque de séquelles perfusionnelles

    by Marc Danguy Des Déserts

    La maladie thromboembolique veineuse (MTEV) est la troisième cause de mortalité cardiovasculaire. L’embolie pulmonaire (EP) est la forme la plus grave de thrombose veineuse. Les patients présentant une EP d’origine non provoquée ont un risque élevé de développer une obstruction vasculaire pulmonaire résiduelle (OVPR). La non-résolution du thrombus augmente le risque de survenue de récidive thromboembolique. Ce travail a pour objectif d’évaluer l’impact de trois mécanismes potentiellement impliqués dans la persistance de thrombus : l’inflammation, la dysfonction endothéliale et la fibrinolyse au sein d’une population atteinte d’EP non provoquée. Un premier travail montre que l’hypofibrinolyse et la dysfonction endothéliale sont impliqués dans les séquelles perfusionnelles au sein d’une population de patients présentant un premier épisode d’EP non provoquée. Un test d’évaluation de coagulation et de fibrinolyse Clôt Lysis Assay (CLA) semi automatisé a été mis en place et les taux de TGFβ1 évalués dans le plasma. Les taux de TGFβ1 mesurés un mois après l’arrêt du traitement anticoagulant sont associés à l’OVPR, tandis que les paramètres de fibrinolyse ne le sont pas. Des paramètres de formation du caillot mesurés par CLA étaient associés à la récidive de la MTEV. Ces résultats permettent de mieux comprendre la physiopathologie de l’OVPR et de la récidive de MTEV afin d’optimiser le traitement de l'EP non provoquée.

  • Open Access

    Optical scattering coefficient measurement of blood plasma during clot formation

    by Lea Abi Nassif, Wadih Khater, Fabrice Pellen, Bernard Le Jeune, Marie Abboud, Marc Danguy Des Déserts, Benjamin Espinasse, Guy Le Brun

    Objective . Venous Thromboembolism (VTE) is a very dangerous and common disease. While approximately 50% of VTE can be attributed to identifiable causes, the remaining half has no known origin and about 30% of this group show recurrence. Monitoring the kinetics of optical scattering properties of plasma during clot formation can provide information on clot structure, which seems to be a relevant parameter to identify patients at risk of recurrence. Approach . This study aims to compare a sensitive and quantitative optical method based on the scattering coefficient μ s measurement, never previously explored in the context of VTE, to the conventional optical density (OD) measurement obtained by a spectrophotometer. Main results . The evolution of eight characteristic parameters, extracted from clot formation curve signatures, was studied as a function of plasma concentration. Significance . Scattering coefficient measurements are sensitive to plasma concentration in the sample, more reproductible, more precise and provide access to new information compared to OD measurements.


  • Open Access

    Influence of mindfulness and coping flexibility in the early phases of burnout development in intensive care unit healthcare workers during the COVID-19 pandemic

    by Damien Claverie, Anaïs Duffaud, Sonia Pellissier, Sandrine Jacob, Cécile Vigier, Marc Danguy Des Déserts, Pierre Pasquier, Jacques Escarment, Frédéric Canini, Marion Trousselard

    Background: Caregivers in intensive care units are exposed to high levels of stress, which were exacerbated during the COVID-19 pandemic, increasing the incidence of stress-related disorders, including burnout. Methods: We evaluated the influence of mindfulness and coping flexibility in the early days of burnout development in a prospective study of 50 military caregivers working in a mobile resuscitation unit during the COVID-19 pandemic. We visited the participants at the end of deployment (day 0; D0) and three weeks later (D21). On D0, the participants completed questionnaires assessing mindfulness (Freiburg Mindfulness Inventory; FMI), coping flexibility (Flexcop), and burnout (Burnout Measure, Short Version; BMS). Subjective sleep symptoms were also assessed to evaluate their relationship with burnout. The BMS was repeated on D21. Results: Four short-term burnout evolutions were observed: (i) “healthy” on D0 and D21; (ii) “exhausted,” healthy on D0 and burnout on D21; (iii) “resilient,” burnout on D0 and healthy on D21; and (iv) “burnout” on D0 and D21. Compared with healthy participants on D0, only resilient participants had lower FMI (η2 = 0.22; p = 0.032). Exhausted participants had more difficulty waking, and burnout participants had higher daytime fatigue than healthy participants. FMI scores on D0 negatively correlated with BMS scores on D21 (r = ‒0.40 r2 = 0.16 p = 0.009) for the entire population, and also after excluding burnout status at D0 (r = ‒0.41 r2 = 0.17 p = 0.02). Flexcop scores on D0 did not correlate with BMS scores on D21. Conclusions: This study underlines the importance of mindfulness in the early days of burnout onset, and suggests considering its reinforcement for prevention of burnout and its measurement as a potential biomarker of burnout risk.

  • Open Access

    Potential association of TGFβ1 plasma levels and fibrinolysis parameters with the risk of recurrence and vascular obstruction after a first unprovoked pulmonary embolism episode

    by Marc Danguy Des Déserts, Claire de Moreuil, Jamal Elhasnaoui, Lenaïck Gourhant, Virginie Gourdou-Latyszenok, Benjamin Espinasse, Juliette Menguy, Cécile Tromeur, Rozenn Le Corre, Raphael Le Mao, et al.

    The pathophysiology of residual pulmonary vascular obstruction (RPVO) and recurrent venous thromboembolism (VTE) after unprovoked pulmonary embolism (PE) remains poorly understood. The purpose was to evaluate fibrinolytic and tissue remodeling markers as indicators of RPVO and recurrence after a first unprovoked PE. Analyses were conducted in the 18 to 70-year-old patients included in the PADIS-PE trial, with a pulmonary vascular obstruction (PVO) index ≥ 30% at PE diagnosis. After an initial six-month vitamin K antagonist treatment, patients were randomised to receive placebo or warfarin for 18 months and assessed for the absence or presence of residual pulmonary vascular obstruction (RPVO < or ≥ 5%, respectively). Quantitative assessment of fibrinolytic (D-dimer, tPA, uPA, TFPI) and tissue remodeling (TGFβ1) markers, and a tissue-factor-based turbidimetric clot lysis assay (CLA) were performed one month after warfarin discontinuation. Symptomatic recurrent VTE was monitored for 42 months after randomisation. Among the 371 patients included in PADIS-PE, 23 fulfilled clinico-radiological criteria and had an available blood sample. Six (26%) patients presented RPVO ≥ 5% and symptomatic recurrent VTE occurred in nine (39%) patients. Clot formation and lysis parameters were not associated with RPVO. TGFβ1 plasma levels were higher in patients with RPVO. Clot formation potential measured with CLA was higher in patients with recurrent VTE. No association between recurrent VTE and TGFβ1 was observed. In adult patients with a first unprovoked PE and a PVO index ≥ 30%, TGFβ1 plasma levels were associated with RPVO, whereas clot formation parameters measured with CLA were associated with VTE recurrence.


  • Effect of a comfort scale compared with a pain numerical rate scale on opioids consumption in postanaesthesia care unit: the COMFORT study

    by Nicolas Fusco, Ludovic Meuret, Franck Bernard, Hervé Musellec, Laure Martin, Mathilde Léonard, Sigismond Lasocki, Thierry Gazeau, Romain Aubertin, Dorothée Blayac, et al.


  • Open Access

    TGFβ1 plasma levels and clot lysis assay to better characterize patients after a first unprovoked episode of pulmonary embolism

    by Marc Danguy Des Deserts, Claire de Moreuil, Jamal Elhasnaoui, Lenaïck Gourhant, Virginie Gourdou-Latyszenok, Benjamin Espinasse, Juliette Menguy, Cécile Tromeur, Rozenn Le Corre, Raphael Le Mao, et al.

    Introduction The pathophysiology of residual pulmonary vascular obstruction (RPVO) and recurrent venous thromboembolism (VTE) after unprovoked pulmonary embolism (PE) remains poorly understood. The purpose was to evaluate fibrinolytic and tissue remodeling markers as indicators of RPVO and recurrence after a first unprovoked PE. Methods Analyses were conducted in the 18 to 70-year-old patients included in the PADIS-PE trial, with a pulmonary vascular obstruction (PVO) index ≥30% at PE diagnosis. After an initial six-month vitamin K antagonist treatment, patients were randomised to receive placebo or warfarin for 18 months, assessed for the absence or presence of residual pulmonary vascular obstruction (RPVO < or ≥5%, respectively) and followed during two years. Quantitative assessment of fibrinolytic (D-dimer, tPA, uPA, TFPI) and tissue remodeling (TGFß1) markers, and a tissue-factor-based turbidimetric clot lysis assay (CLA) were performed one month after warfarin discontinuation. Results Among the 371 patients included in the PADIS-PE trial, 23 were eligible. Six (26%) patients presented RPVO, symptomatic recurrent VTE occurred in nine (39%) patients. Clot formation and lysis parameters were not associated with RPVO. TGFß1 plasma levels were higher in patients with RPVO. Clot formation potential measured with CLA was higher in patients with recurrent VTE. No association between recurrent VTE and TGFß1 was observed. In multivariable analysis, time to peak was associated with VTE recurrence. Conclusion In adult patients with a first unprovoked PE and a PVO index ≥30%, TGFß1 plasma level was associated with RPVO, whereas clot formation parameters measured with CLA were associated with VTE recurrence.

  • The best way to prepare for such a CBRN conflict: Improving casualty management performance

    by Johan Schmitt, Marc Danguy Des Déserts, Chloé Thill, Christophe Giacardi, Fabrice Entine

  • ACTIfit™ : 38 % de résorption complète à 8 ans de recul sur une cohorte de 18 cas

    by Antoine de Chanterac, Marc Garetier, François-Xavier Gunepin, Cécile Baynat, Marc Danguy Des Déserts, Arnaud Perchoc, Hoel Letissier, Christophe Andro

  • Who to trust? Clinical and biological cross-talking in traumatic induced coagulopathy

    by Johan Schmitt, Marc Danguy Des Deserts, Philippe Aries, Christophe Giacardi

    An abstract is unavailable. This article is available as a PDF only.

  • Advances in trauma care to save lives from traumatic injury: A narrative review

    by Johan Schmitt, Jennifer Gurney, Philippe Aries, Marc Danguy Des Deserts

    Recent advances on trauma management from the prehospital setting to in hospital care led to a better surviving severe trauma rate. Mortality from exsanguination remains the first preventable mortality. Damage-control resuscitation and surgery are evolving and thus some promising concepts are developing. Transfusion toolkit is brought on the prehospital scene while temporary bridge to hemostasis may be helpful. Panel transfusion products allow an individualized ratio assumed by fresh frozen or lyophilized plasma, fresh or cold-stored whole blood, fibrinogen, four-factor prothrombin complex concentrates. Growing interest is raising in whole blood transfusion, resuscitative endovascular balloon occlusion of the aorta use, hybrid emergency room, viscoelastic hemostatic assays to improve patient outcomes. Microcirculation, traumatic endotheliopathy, organ failures and secondary immunosuppression are point out since late deaths are increasing and may deserve specific treatment. As each trauma patient follows his own course over the following days after trauma, trauma management may be seen through successive, temporal, and individualized aims.